Laconia Ventures
VC Fund
New York, United States
Laconia Ventures is a New York City-based venture capital firm that provides early-stage funding and strategic resources for inspired entrepreneurs in the information technology sector.Our goal is to work closely with entrepreneurs and their lead investors to build sustained, scalable, competitive advantage by applying our capital, experience,and professional network to their unique ideas and emerging businesses. We invest in companies that leverage technology and crowd-sourced community to disrupt the traditional structure of industries for increased consumer value and market reinvention. We have specific expertise and interest in the Digital Media, Data Analytics, Mobile, Social, and Ad Technology sectors.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 7%
- Fund size:
- $5M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Laconia Ventures invests in
Stages Laconia Ventures invests in
Countries Laconia Ventures invests in
Round sizes
Round size
- Seed
- $458k–$5.2M
- Series A
- $1.4M–$9.5M
Investment Focus
Industry
- Advertising 10 (22%)
- Software 9 (20%)
- SaaS 5 (11%)
- Video 5 (11%)
- Mobile 5 (11%)
Stage
- Seed 22 (49%)
- Series A 7 (16%)
- Venture - Series Unknown 3 (7%)
- Angel 2 (4%)
- Pre-Seed 2 (4%)
Country
- United States 31 (69%)
- Canada 3 (7%)
- Israel 1 (2%)
- Cayman Islands 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Brooklyn Health is a company of clinicians, scientists, and engineers dedicated to enhancing digital health measurement. | $6.5M / Seed / May 27, 2025 | ||
| Trestle brings the fragmented construction contracting and procurement process under a single roof using automation, integration, and A.I. to increase process efficiency, data transparency, and provide contractors with a real-time learning loop. Trestle Benchmark let's construction organizations capture reviews on how their vendors perform andcombine this data with other internal and external sources into a single powerful vendor profile for project risk management. | $2.3M / Pre-Seed / Sep 04, 2024 | ||
| Auxa Health is a VC-backed healthcare technology firm focused on social care orchestration. Auxa’s tools, technology, and services proactively identify the right benefits for individuals and take on the work of enrollment. Our end-to-end support ensures that people are connected to the resources they need, while reducing the administrative burdenfor individuals, caregivers, and providers. | $5.2M / Seed / Apr 22, 2024 | ||
| Wavy empowers people leaders to create amazing company culture, wherever their teams are located. Through our Culture Management Platform and Experiences Marketplace, clients can use Wavy to plan, execute, review, and improve their events and culture and team building initiatives. | $2M / Seed / Apr 11, 2022 | ||
| Marpipe is a multivariate creative testing platform. | $8M / Series A / Sep 07, 2021 | ||
| The Index Coop is a decentralized autonomous organization (DAO) and the largest provider of on-chain structured decentralized finance (DeFi) products. We’re on a mission to make DeFi simple, secure and accessible to everyone. Index Coop builds sector index products, leverage and inverse products, and yield-generating products, all built on SetProtocol’s twice-audited V2 infrastructure. | $7.7M / Seed / Jul 07, 2021 | ||
| Paloma powers e-com on messaging channels, giving brands 2–10X higher conversion rates compared to their websites. This full-suite commerce SaaS platform rapidly generates the most efficient shopping experiences – all while collecting millions of customer data points, seamlessly feeding insights back to brands. | $4M / Seed / Jun 02, 2021 | ||
| Riley is an artificial intelligence-powered personal assistant. It is used by salespeople to create contacts and store information for them, ready for whenever they need it, taking the work out of working with their CRM. As a result, they can close more deals and build genuine relationships. | $1.9M / Pre-Seed / Mar 01, 2021 | ||
| AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The company empowers advancements in human neuroscience and accelerates the drug development process through its drug discovery platforms, NerveSim and BrainSim.AxoSim was founded in 2014 and isbased in New Orleans, Louisiana. | Seed / Apr 01, 2017 | ||
| 28bio is a biotechnology company focused on bridging the gap between human brain biology and drug development using proprietary neurotechnology. Its platform integrates tissue engineering, neural interfacing, and artificial intelligence to build engineered human brain organoids that mimic memory, learning, and other cognitive functions. The goal isto provide more predictive and human-relevant models to improve the success rates of neurological drug discovery, reducing reliance on traditional animal models. | Seed / Apr 01, 2017 | ||
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Laconia Ventures invest in?
Laconia Ventures invests primarily in Advertising, Software and SaaS startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Laconia Ventures's check size?
Laconia Ventures typically joins rounds of $458k–$5.2M at Seed and $1.4M–$9.5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Laconia Ventures participates in.
When did Laconia Ventures last invest?
The most recent investment recorded for Laconia Ventures closed in May 2025. Shizune tracks 45 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
